Group One Trading’s Biocept, Inc. BIOC Stock Holding History

Group One Trading’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-197	Closed	-$5K	–	8378
2022 Q3	$5K	Sell	197 -30	-13%	-$888	﹤0.01%	6878
2022 Q2	$6K	Sell	227 -343	-60%	-$15.6K	﹤0.01%	7062
2022 Q1	$40K	Buy	570 +353	+163%	+$27.7K	﹤0.01%	6282
2021 Q4	$24K	Buy	217 +210	+3,000%	+$24.2K	﹤0.01%	6879
2021 Q3	$1K	Sell	7 -333	-98%	-$38.9K	﹤0.01%	8066
2021 Q2	$43K	Buy	340 +120	+55%	+$16.2K	﹤0.01%	6713
2021 Q1	$336K	Buy	+220	New	+$39.9K	﹤0.01%	4470
2017 Q4	–	Sell	-9	Closed	-$104K	–	5361
2017 Q3	$104K	Sell	9 -1	-10%	-$11.8K	﹤0.01%	3218
2017 Q2	$125K	Buy	+10	New	+$141K	﹤0.01%	2977

Group One Trading's BIOC Position: Q4 2023 in Review

Group One Trading sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 270 shares — an estimated $338 sold.

Group One Trading first reported a position in BIOC in Q3 2018 and held it in 18 quarters. The position peaked at $63K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.

Group One Trading reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 270 Biocept, Inc. shares in Q4 2023, an estimated $338.
Group One Trading first reported a position in Biocept, Inc. in Q3 2018 and held it in 18 quarters.
Group One Trading's Biocept, Inc. position peaked at $63K in Q4 2021.
0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.